Stock Track | Medpace Soars 15.54% in After-Hours Trading on Strong Q2 Earnings Beat and Raised Guidance

Stock Track

Jul 23

Medpace Holdings Inc. (NASDAQ: MEDP) experienced a significant surge of 15.54% in after-hours trading, driven by the release of its second-quarter financial results for fiscal year 2026 that substantially exceeded analyst expectations.

The clinical research organization reported Q2 earnings per share of $4.25, beating the consensus estimate of $3.97 by 7.05% and representing a 37.1% increase from the same period last year. Quarterly revenue reached $707.331 million, surpassing the estimated $687.647 million by 2.86% and climbing 17.2% year-over-year. Additionally, the company demonstrated strong operational performance with net new business awards jumping 28.2% to $795.7 million.

Further bolstering investor sentiment, Medpace provided optimistic full-year guidance, forecasting revenue between $2.81 billion and $2.89 billion and earnings per share of $17.25 to $17.95 for 2026, both ranges above consensus analyst estimates.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1103525133"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1103525133\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1103525133?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-23 09:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1103525133","market":"hk","top_or_hot":-1,"title":"Stock Track | Medpace Soars 15.54% in After-Hours Trading on Strong Q2 Earnings Beat and Raised Guidance","media":"Stock Track","content":"<p>Medpace Holdings Inc. (NASDAQ: MEDP) experienced a significant surge of 15.54% in after-hours trading, driven by the release of its second-quarter financial results for fiscal year 2026 that substantially exceeded analyst expectations.</p><p>The clinical research organization reported Q2 earnings per share of $4.25, beating the consensus estimate of $3.97 by 7.05% and representing a 37.1% increase from the same period last year. Quarterly revenue reached $707.331 million, surpassing the estimated $687.647 million by 2.86% and climbing 17.2% year-over-year. Additionally, the company demonstrated strong operational performance with net new business awards jumping 28.2% to $795.7 million.</p><p>Further bolstering investor sentiment, Medpace provided optimistic full-year guidance, forecasting revenue between $2.81 billion and $2.89 billion and earnings per share of $17.25 to $17.95 for 2026, both ranges above consensus analyst estimates.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Medpace Soars 15.54% in After-Hours Trading on Strong Q2 Earnings Beat and Raised Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Medpace Soars 15.54% in After-Hours Trading on Strong Q2 Earnings Beat and Raised Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-07-23 09:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Medpace Holdings Inc. (NASDAQ: MEDP) experienced a significant surge of 15.54% in after-hours trading, driven by the release of its second-quarter financial results for fiscal year 2026 that substantially exceeded analyst expectations.</p><p>The clinical research organization reported Q2 earnings per share of $4.25, beating the consensus estimate of $3.97 by 7.05% and representing a 37.1% increase from the same period last year. Quarterly revenue reached $707.331 million, surpassing the estimated $687.647 million by 2.86% and climbing 17.2% year-over-year. Additionally, the company demonstrated strong operational performance with net new business awards jumping 28.2% to $795.7 million.</p><p>Further bolstering investor sentiment, Medpace provided optimistic full-year guidance, forecasting revenue between $2.81 billion and $2.89 billion and earnings per share of $17.25 to $17.95 for 2026, both ranges above consensus analyst estimates.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MEDP","symbol_name":"Medpace Holdings Inc.","start_time":0,"source_url":"","article_id":"1103525133","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1103525133","pubTimestamp":1784771352,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Medpace Holdings Inc. (NASDAQ: MEDP) experienced a significant surge of 15.54% in after-hours trading, driven by the release of its second-quarter financial results for fiscal year 2026 that...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MEDP":"Medpace Holdings Inc."},"translate_title":"股票跟踪 | 由于第二季度盈利强劲并上调指引，Medpace 在盘后交易中飙升 15.54%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MEDP":1},"content_text":"Medpace Holdings Inc. (NASDAQ: MEDP) experienced a significant surge of 15.54% in after-hours trading, driven by the release of its second-quarter financial results for fiscal year 2026 that substantially exceeded analyst expectations.The clinical research organization reported Q2 earnings per share of $4.25, beating the consensus estimate of $3.97 by 7.05% and representing a 37.1% increase from the same period last year. Quarterly revenue reached $707.331 million, surpassing the estimated $687.647 million by 2.86% and climbing 17.2% year-over-year. Additionally, the company demonstrated strong operational performance with net new business awards jumping 28.2% to $795.7 million.Further bolstering investor sentiment, Medpace provided optimistic full-year guidance, forecasting revenue between $2.81 billion and $2.89 billion and earnings per share of $17.25 to $17.95 for 2026, both ranges above consensus analyst estimates.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}